News outlets report on the Bill & Melinda Gates Foundation’s pledge of $5.7 million to test experimental Ebola treatments in West Africa.

BBC News: Ebola outbreak: $5.7m pledged for blood plasma trials
“The Bill & Melinda Gates Foundation has pledged $5.7m towards a program to increase production of experimental Ebola treatments in Guinea and other affected countries…” (11/18).

Bloomberg News: Gates to Fund Ebola Survivor Blood, Chimerix Drug Trials
“The Bill & Melinda Gates Foundation committed $5.7 million to help produce and test potential blood-based therapies and antiviral treatments for Ebola. The funds will support efforts in West Africa to evaluate plasma and other blood products from survivors of Ebola virus disease as a means of treating the infection in others, the Seattle-based foundation said in an e-mailed Nov. 18 statement. Various drug candidates will also be tested, including Chimerix Inc. (CMRX)’s antiviral brincidofovir…” (Gale, 11/18).